Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,494 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome.
Hosoi H, Imadome KI, Tamura S, Kuriyama K, Murata S, Yamashita Y, Mushino T, Oiwa T, Kobata H, Nishikawa A, Nakakuma H, Hanaoka N, Isobe Y, Ohshima K, Sonoki T. Hosoi H, et al. Among authors: yamashita y. Leuk Res. 2017 Apr;55:1-5. doi: 10.1016/j.leukres.2017.01.022. Epub 2017 Jan 15. Leuk Res. 2017. PMID: 28110206
Enforced expression of MIR142, a target of chromosome translocation in human B-cell tumors, results in B-cell depletion.
Kuriyama K, Enomoto Y, Suzuki R, Watanuki J, Hosoi H, Yamashita Y, Murata S, Mushino T, Tamura S, Hanaoka N, Dyer M, Siebert R, Kiyonari H, Nakakuma H, Kitamura T, Sonoki T. Kuriyama K, et al. Among authors: yamashita y. Int J Hematol. 2018 Mar;107(3):345-354. doi: 10.1007/s12185-017-2360-8. Epub 2017 Oct 25. Int J Hematol. 2018. PMID: 29071477
EBV-positive nodal low-grade B-cell lymphoma with BCL3, IgA and IRTA1 expression: Is this a polymorphic lymphoproliferative disorder or an EBV-positive nodal marginal zone lymphoma?
Fujimoto M, Yamashita Y, Haga H, Akasaka T, Iwahashi Y, Warigaya K, Kojima F, Hama Y, Tamura S, Sonoki T, Murata SI. Fujimoto M, et al. Among authors: yamashita y. Pathol Int. 2018 Sep;68(9):538-540. doi: 10.1111/pin.12687. Epub 2018 Jun 19. Pathol Int. 2018. PMID: 29920862 No abstract available.
Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.
Yamashita Y, Nishikawa A, Iwahashi Y, Fujimoto M, Sasaki I, Mishima H, Kinoshita A, Hemmi H, Kanazawa N, Ohshima K, Imadome KI, Murata SI, Yoshiura KI, Kaisho T, Sonoki T, Tamura S. Yamashita Y, et al. Int J Hematol. 2019 Jun;109(6):744-750. doi: 10.1007/s12185-019-02595-0. Epub 2019 Jan 31. Int J Hematol. 2019. PMID: 30706328
5,494 results